By Harold W. Reid, The Chicago Times
June 17, 2022
WASHINGTON – The Food and Drug Administration approved COVID-19 vaccinations for infants allowing for vaccinations to begin next week.
The FDA approved the use of shots from Moderna and Pfizer for nearly 18 million juveniles under the age of 5. However, the Centers for Disease Control and Prevention’s independent advisers have begun debating the two-dose Moderna and the three-dose Pfizer vaccines on Friday and will make its ruling on Saturday
The Biden administration has been readying the vaccine program for infants throughout the nation by preordering millions of doses. The FDA’s emergency use authorization allows manufacturers to ship across the nation. Moderna and Pfizer have admitted that their vaccinations do show side effects of fever and fatigue.
Currently, Pfizer’s vaccine for juveniles is one-tenth of the adult dose. Three shots are needed with the first two given three weeks apart and the last dose two months later.
Moderna’s vaccine requires two shots and are each a quarter of the adult dose. The Moderna dose is given about four weeks apart for juveniles under the age of 6.